Home               Contact Us                  Links                     Disclaimer   

Search:

 

 

SUBSCRIBE (always Free)

  • To our Medical Device news subscription

  • Article Notification (every time a new one is added)

  • Newsletter

Subscribe

 

 

   


 

Preparing for Your FDA Inspection

...cont'd

 
   

 

 

What Questions Will the FDA Probably Ask?

The QSIT script is available on the FDA's website at the following web address:

http://www.fda.gov/ora/inspect_ref/igs/qsit/qsitguide.htm

If you haven’t done so already download a copy!  It’s free! It tells you (most probably) the questions the FDA is going to ask.  It’s like getting the questions to the final exam!

The Scribe: Keeping A Record of your FDA Audit

Maintaining a detailed record of an FDA audit is important.  The outcome of an audit may vary depending on many circumstances and in some cases may result in observations that may have been taken out of context by the auditor.  A good record will allow you to double check the circumstances surrounding the observations by the FDA and if applicable this can provide you with information you can use to contest an observation.  Another important reason to keep a good record is to allow you to go back and observe what you did wrong - or did right.  

During an FDA audit it would be wise to have a member of your staff act as a scribe.  Having someone else who is solely responsible for taking notes allows you and the other members to fully devote your attention to the auditor.  The scribe should take detailed notes with regards to what the auditor observes and does.  For instance if the auditor looks at any particular products during a facility tour, your scribe should take note of the lot numbers, etc. If the FDA elects to take samples, you should definitely keep a record of what was taken.

The scribe should note all the documents that have been reviewed by the FDA.  In additional all copies of documentation taken by the FDA should be stamped as "Confidential" (especially if they are proprietary) and preferably photocopied (and kept by the firm) or at the very least keep a detailed account of what the FDA has taken (including version numbers in the case of procedures).  The "confidential" stamp tells the FDA that the document they are looking at may contain proprietary information.  This will keep the information from being readily accessible by way of the Freedom of Information (FOI) act.  

Your scribe should also take careful notes on who participates in the audit.  At times you may call on to different members of your organization to come and discuss certain aspects of the business to the FDA. Your scribe should note the names of all participants including those that come in contact with the FDA during your facility tour. The scribe should also note what the participant does, says and provides to the FDA.

You may want to choose your scribe very carefully.  It would be best to select someone who is very knowledgeable of FDA requirements as well as your own procedures.  The reason for this is that a knowledgeable scribe can make detailed observations that involve close calls and other activities that are of a noncompliant nature.  For instance while you are busy explaining some part of your process to the FDA inspector there may be someone in the facility that is violating some important GMP requirement.  

During the course of an audit you may make promises or suggestions to the FDA.  Your scribe should be instructed to take note of these.  It goes without saying that you should only promise to do something if your intent is to do it.  The FDA will hold you to your promise.  Make sure your scribe notes these commitments.  

Finally it is recommended that you take note of all FDA recommendations/suggestions.

It goes without saying that you probably need to go into the audit with the anticipation of recording everything.


Conclusion

One final word:  It is recommended that you funnel all the answers through one person at a time.  The person answering the questions should ensure that the communications to the FDA are kept laconic and honest.  Avoid small talk. 

END

Start of Article   

.

   
  © Medical Device School 2005